Oxford VR, a spin-out from Oxford University, it develops psychological interventions based on proven treatment protocols and deliver them using state-of-the-art immersive virtual reality technology.
Oxford VR is transforming mental health for millions with VR therapy.
Oxford VR was founded in 2017 by Daniel Freeman, alongside with Barnaby Perks and Jason Freeman. The company is headquartered in Oxford, with offices in Cambridge and London.
Oxford VR is focused on developing evidence-based automated VR therapy to treat mental health conditions with significant impact on patients, the health system and wider economy.
Oxford VR provides millions of individuals with high-quality mental health treatment which users report is fun and enjoyable to do, and is also faster and more effective than traditional treatments and can be delivered at a significantly lower cost to health providers.
Oxford VR's therapy is delivered by a virtual coach and compliments face-to-face therapy, enabling greater access to high-quality treatment.
Oxford VR is backed by Optum Ventures, Luminous Ventures, Oxford Sciences Innovation, Oxford University Innovation and GT Healthcare Capital Partners. The company raised £10M in a Series A round on Feb 12, 2020. This brings Oxford VR's total funding to £13.2M to date.